The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Open accessAbstract
Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface, predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural mesothelioma underway, and incidence rates are predicted to peak in the next few years. This article summarises the epidemiology and pathogenesis of malignant pleural mesothelioma, before describing some key factors in the patient experience and outlining common symptoms. Diagnostic approaches are reviewed, including imaging techniques and the role of various biomarkers. Treatment options are summarised, including the importance of palliative care and methods of controlling pleural effusions. The evidence for chemotherapy, radiotherapy and surgery is reviewed, both in the palliative setting and in the context of trimodality treatment. An algorithm for managing malignant pleural effusion in malignant pleural mesothelioma patients is presented. Finally new treatment developments and novel therapeutic approaches are summarised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011) · The Lancet · doi:10.1016/s0140-6736(11)60993-8 · Cited by 3,075
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
Zalcman, G., Mazieres, J., Margery, J., Greillier, L., Audigier-Valette, C., Moro-Sibilot, D., Molinier, O., Corre, R., Monnet, I., Gounant, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01238-6 · Cited by 968
Advances in Malignant Mesothelioma
Robinson, B. W. S., & Lake, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 889
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
Roberts, M. E., Neville, E., Berrisford, R. G., Antunes, G., Ali, N. J., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136994 · Cited by 885
Beatty, G. L., Haas, A. R., Maus, M. V., Torigian, D. A., Soulen, M. C., Plesa, G., Chew, A., Zhao, Y., Levine, B. L., Albelda, S. M., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0170 · Cited by 864
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Emens, L. A., & Middleton, G. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0064 · Cited by 831
Hooper, C., Lee, Y. C. G., Maskell, N., & on behalf of the BTS Pleural Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136978 · Cited by 824
Self-citationPleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010
Havelock, T., Teoh, R., Laws, D., Gleeson, F., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.137026 · Cited by 794
Treasure, T., Lang-Lazdunski, L., Waller, D., Bliss, J. M., Tan, C., Entwisle, J., Snee, M., O'Brien, M., Thomas, G., Senan, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70149-8 · Cited by 708
Davies, H. E., Mishra, E. K., Kahan, B. C., Wrightson, J. M., Stanton, A. E., Guhan, A., Davies, C. W. H., Grayez, J., Harrison, R., Prasad, A., et al. (2012) · JAMA · doi:10.1001/jama.2012.5535 · Cited by 657
Scherpereel, A., Astoul, P., Baas, P., Berghmans, T., Clayson, H., de Vuyst, P., Dienemann, H., Galateau-Salle, F., Hennequin, C., Hillerdal, G., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00063109 · Cited by 638
Flores, R. M., Pass, H. I., Seshan, V. E., Dycoco, J., Zakowski, M., Carbone, M., Bains, M. S., & Rusch, V. W. (2008) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.10.054 · Cited by 617
van Meerbeeck, J. P., Gaafar, R., Manegold, C., Van Klaveren, R. J., Van Marck, E. A., Vincent, M., Legrand, C., Bottomley, A., Debruyne, C., & Giaccone, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.20005.14.589 · Cited by 617
A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma
(1995) · Chest · doi:10.1378/chest.108.4.1122 · Cited by 606
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
Inui, A. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.2.72 · Cited by 579
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion
Dresler, C. M., Olak, J., Herndon, J. E., Richards, W. G., Scalzetti, E., Fleishman, S. B., Kernstine, K. H., Demmy, T., Jablons, D. M., Kohman, L., et al. (2005) · Chest · doi:10.1378/chest.127.3.909 · Cited by 578
Herndon, J. E., Green, M. R., Chahinian, A. P., Corson, J. M., Suzuki, Y., & Vogelzang, N. J. (1998) · Chest · doi:10.1378/chest.113.3.723 · Cited by 504
Rusch, V. W., Rosenzweig, K., Venkatraman, E., Leon, L., Raben, A., Harrison, L., Bains, M. S., Downey, R. J., & Ginsberg, R. J. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.116560 · Cited by 493
Krug, L. M., Pass, H. I., Rusch, V. W., Kindler, H. L., Sugarbaker, D. J., Rosenzweig, K. E., Flores, R., Friedberg, J. S., Pisters, K., Monberg, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.3943 · Cited by 467
Boutin, C., Rey, F., & Viallat, J.-R. (1995) · Chest · doi:10.1378/chest.108.3.754 · Cited by 464
Chemical Pleurodesis for Malignant Pleural Effusions
Walker-Renard, P. B., Vaughan, L. M., & Sahn, S. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00010 · Cited by 416
Simian virus 40-like DNA sequences in human pleural mesothelioma.
Carbone, M., Pass, H. I., Rizzo, P., Marinetti, M. R., Muzio, M. D., Mew, D., Levine, A. S., & Procopio, A. D. (1994) · PubMed · Cited by 397
Sugarbaker, D. J., Jaklitsch, M. T., Bueno, R., Richards, W. G., Lukanich, J. M., Mentzer, S. J., Colson, Y. L., Linden, P. A., Chang, M. Y., Capalbo, L., et al. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.02.021 · Cited by 395
Socinski, M. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1335 · Cited by 379
Calabrò, L., Morra, A., Fonsatti, E., Cutaia, O., Amato, G., Giannarelli, D., Di Giacomo, A. M., Danielli, R., Altomonte, M., Mutti, L., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70381-4 · Cited by 356
Ohta, Y., Shridhar, V, Bright, R. K., Kalemkerian, G. P., Du, W., Carbone, M., Watanabe, Y., & Pass, H. I. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690650 · Cited by 335
Guo, G., Chmielecki, J., Goparaju, C., Heguy, A., Dolgalev, I., Carbone, M., Seepo, S., Meyerson, M., & Pass, H. I. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1008 · Cited by 321
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
Rusch, V. W., Giroux, D., Kennedy, C., Ruffini, E., Cangir, A. K., Rice, D., Pass, H., Asamura, H., Waller, D., Edwards, J., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826915f1 · Cited by 308
Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma
Ceresoli, G. L., Zucali, P. A., Favaretto, A. G., Grossi, F., Bidoli, P., Del Conte, G., Ceribelli, A., Bearz, A., Morenghi, E., Cavina, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3190 · Cited by 296
Malignant mesothelioma 1982: Review of 4710 published cases
Hillerdal, G. (1983) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(83)90068-2 · Cited by 289
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
Heelan, R. T., Rusch, V. W., Begg, C. B., Panicek, D. M., Caravelli, J. F., & Eisen, C. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.172.4.10587144 · Cited by 289
Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
Pass, H. I., Levin, S. M., Harbut, M. R., Melamed, J., Chiriboga, L., Donington, J., Huflejt, M., Carbone, M., Chia, D., Goodglick, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1115050 · Cited by 283
Molecular pathogenesis of malignant mesothelioma
Sekido, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt166 · Cited by 279
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma
Cao, C., Tian, D., Park, J., Allan, J., Pataky, K. A., & Yan, T. D. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.026 · Cited by 261
Muers, M. F., Stephens, R. J., Fisher, P., Darlison, L., Higgs, C. M., Lowry, E., Nicholson, A. G., O'Brien, M., Peake, M., Rudd, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60727-8 · Cited by 260
Bénard, F., Sterman, D., Smith, R. J., Kaiser, L. R., Albelda, S. M., & Alavi, A. (1998) · Chest · doi:10.1378/chest.114.3.713 · Cited by 260
Govindan, R., Kratzke, R. A., Herndon, J. E., Niehans, G. A., Vollmer, R., Watson, D., Green, M. R., Kindler, H. L., & on behalf of the Cancer and Leukemia Group B (CALGB 30101) (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1940 · Cited by 260
Santoro, A., O'Brien, M. E., Stahel, R. A., Nackaerts, K., Baas, P., Karthaus, M., Eberhardt, W., Paz-Ares, L., Sundstrom, S., Liu, Y., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31817c73d6 · Cited by 255
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes
Carbone, M., Emri, S., Dogan, A. U., Steele, I., Tuncer, M., Pass, H. I., & Baris, Y. I. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2068 · Cited by 253
Kennedy, L., Rusch, V. W., Strange, C., Ginsberg, R. J., & Sahn, S. A. (1994) · Chest · doi:10.1378/chest.106.2.342 · Cited by 246
Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils
Torti, D., & Trusolino, L. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100176 · Cited by 246
Van Schil, P. E., Baas, P., Gaafar, R., Maat, A. P., Van de Pol, M., Hasan, B., Klomp, H. M., Abdelrahman, A. M., Welch, J., & van Meerbeeck, J. P. (2010) · European Respiratory Journal · doi:10.1183/09031936.00039510 · Cited by 243
Sugarbaker, D. J., Garcia, J. P., Richards, W. G., Harpole, D. H., Healy-Baldini, E., DeCamp, M. M., Mentzer, S. J., Liptay, M. J., Strauss, G. M., & Swanson, S. J. (1996) · Annals of Surgery · doi:10.1097/00000658-199609000-00005 · Cited by 237
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
van Zandwijk, N., Clarke, C. G. D., Henderson, D. W., Musk, A. W., Fong, K. M., Nowak, A. K., Loneragan, R., McCaughan, B. C., Boyer, M. J., Feigen, M., et al. (2013) · PubMed · doi:10.3978/j.issn.2072-1439.2013.11.28 · Cited by 235
The Role of Cytologic Evaluation of Pleural Fluid in the Diagnosis of Malignant Mesothelioma
Renshaw, A. A., Dean, B. R., Cibas, E. S., Antman, K. H., & Sugarbaker, D. J. (1997) · Chest · doi:10.1378/chest.111.1.106 · Cited by 231
Jassem, J., Ramlau, R., Santoro, A., Schuette, W., Chemaissani, A., Hong, S., Blatter, J., Adachi, S., Hanauske, A., & Manegold, C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.9887 · Cited by 231
SV40 induces mesotheliomas in hamsters.
Cicala, C., Pompetti, F., & Carbone, M. (1993) · PubMed · Cited by 230
Hollevoet, K., Reitsma, J. B., Creaney, J., Grigoriu, B. D., Robinson, B. W., Scherpereel, A., Cristaudo, A., Pass, H. I., Nackaerts, K., Rodríguez Portal, J. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6671 · Cited by 230
Rahman, N. M., Pepperell, J., Rehal, S., Saba, T., Tang, A., Ali, N., West, A., Hettiarachchi, G., Mukherjee, D., Samuel, J., et al. (2015) · JAMA · doi:10.1001/jama.2015.16840 · Cited by 230
Self-citationInterventions for the management of malignant pleural effusions: a network meta-analysis
Clive, A. O., Jones, H. E., Bhatnagar, R., Preston, N. J., & Maskell, N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010529.pub2 · Cited by 228
Self-citationA multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
Nowak, A. K., Byrne, M. J., Williamson, R., Ryan, G., Segal, A., Fielding, D., Mitchell, P., Musk, A. W., & Robinson, B. W. S. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600505 · Cited by 225
Rintoul, R. C., Ritchie, A. J., Edwards, J. G., Waller, D. A., Coonar, A. S., Bennett, M., Lovato, E., Hughes, V., Fox-Rushby, J. A., & Sharples, L. D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60418-9 · Cited by 224
Richards, W. G., Zellos, L., Bueno, R., Jaklitsch, M. T., Jänne, P. A., Chirieac, L. R., Yeap, B. Y., Dekkers, R. J., Hartigan, P. M., Capalbo, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6813 · Cited by 223
Garland, L. L., Rankin, C., Gandara, D. R., Rivkin, S. E., Scott, K. M., Nagle, R. B., Klein-Szanto, A. J. P., Testa, J. R., Altomare, D. A., & Borden, E. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7634 · Cited by 221
Flores, R. M., Akhurst, T., Gonen, M., Larson, S. M., & Rusch, V. W. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00207-1 · Cited by 217
Global Magnitude of Reported and Unreported Mesothelioma
Park, E.-K., Takahashi, K., Hoshuyama, T., Cheng, T.-J., Delgermaa, V., Le, G. V., & Sorahan, T. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002845 · Cited by 216
Yates, D. H., Corrin, B., Stidolph, P. N., & Browne, K. (1997) · Thorax · doi:10.1136/thx.52.6.507 · Cited by 210
López-Ríos, F., Illei, P. B., Rusch, V., & Ladanyi, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17102-x · Cited by 208
Calabrò, L., Morra, A., Fonsatti, E., Cutaia, O., Fazio, C., Annesi, D., Lenoci, M., Amato, G., Danielli, R., Altomonte, M., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00092-2 · Cited by 206
Stahel, R. A., Riesterer, O., Xyrafas, A., Opitz, I., Beyeler, M., Ochsenbein, A., Früh, M., Cathomas, R., Nackaerts, K., Peters, S., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00208-9 · Cited by 202
Pass, H. I., Temeck, B. K., Kranda, K., Thomas, G., Russo, A., Smith, P., Friauf, W., & Steinberg, S. M. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02303746 · Cited by 197
Berghmans, T., Paesmans, M., Lalami, Y., Louviaux, I., Luce, S., Mascaux, C., Meert, A. P., & Sculier, J. P. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00180-0 · Cited by 190
Rimner, A., Zauderer, M. G., Gomez, D. R., Adusumilli, P. S., Parhar, P. K., Wu, A. J., Woo, K. M., Shen, R., Ginsberg, M. S., Yorke, E. D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.2675 · Cited by 190
A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma
O’Rourke, N., Garcia, J. C., Paul, J., Lawless, C., McMenemin, R., & Hill, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.022 · Cited by 180
Hassan, R., Kindler, H. L., Jahan, T., Bazhenova, L., Reck, M., Thomas, A., Pastan, I., Parno, J., O'Shannessy, D. J., Fatato, P., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0804 · Cited by 180
Bydder, S., Phillips, M., Joseph, D. J., Cameron, F., Spry, N. A., DeMelker, Y., & Musk, A. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601957 · Cited by 179
BTS statement on malignant mesothelioma in the UK, 2007
British Thoracic Society Standards of Care Committee (2007) · Thorax · doi:10.1136/thx.2007.087619 · Cited by 176
Metintas, M., Ucgun, I., Elbek, O., Erginel, S., Metintas, S., Kolsuz, M., Harmanci, E., Alatas, F., Hillerdal, G., Ozkan, R., et al. (2002) · European Journal of Radiology · doi:10.1016/s0720-048x(01)00426-0 · Cited by 173
Hassan, R., Sharon, E., Thomas, A., Zhang, J., Ling, A., Miettinen, M., Kreitman, R. J., Steinberg, S. M., Hollevoet, K., & Pastan, I. (2014) · Cancer · doi:10.1002/cncr.28875 · Cited by 168
Lang-Lazdunski, L., Bille, A., Lal, R., Cane, P., McLean, E., Landau, D., Steele, J., & Spicer, J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824ab6c5 · Cited by 166
Clive, A. O., Taylor, H., Dobson, L., Wilson, P., de Winton, E., Panakis, N., Pepperell, J., Howell, T., Stewart, S. A., Penz, E., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30095-x · Cited by 166
Self-citationMRI and CT in the Differential Diagnosis of Pleural Disease
Hierholzer, J., Luo, L., Bittner, R. C., Stroszczynski, C., Schro¨der, R.-J., Schoenfeld, N., Dorow, P., Loddenkemper, R., & Grassot, A. (2000) · CHEST Journal · doi:10.1378/chest.118.3.604 · Cited by 157
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
Stebbing, J., Powles, T. B., McPherson, K., Shamash, J., Wells, P., Sheaff, M. T., Slater, S., Rudd, R., Fennell, D. A., & Steele, J. P. C. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.04.001 · Cited by 155
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma
Ceresoli, G. L., Zucali, P. A., Vincenzo, F. D., Gianoncelli, L., Simonelli, M., Lorenzi, E., Ripa, C., Giordano, L., & Santoro, A. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.12.004 · Cited by 150
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
Creaney, J., Dick, I. M., Meniawy, T. M., Leong, S. L., Leon, J. S., Demelker, Y., Segal, A., Musk, A. W., Lee, G., Skates, S. J., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205205 · Cited by 146
Ostroff, R. M., Mehan, M. R., Stewart, A., Ayers, D. G., Brody, E. N., Williams, S. A., Levin, S. M., Black, B., Harbut, M. R., Carbone, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046091 · Cited by 145
Castagneto, B., Botta, M., Aitini, E., Spigno, F., Degiovanni, D., Alabiso, O., Serra, M., Muzio, A., Carbone, R. G., Buosi, R., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm501 · Cited by 141
de Perrot, M. E., Feld, R. D., Leighl, N. B., Hope, A. J., Waddell, T. K., Keshavjee, S. H., & Cho, J. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.09.129 · Cited by 138
Advances in the systemic therapy of malignant pleural mesothelioma
Fennell, D. A., Gaudino, G., O'Byrne, K. J., Mutti, L., & van Meerbeeck, J. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1039 · Cited by 136
Beckett, P., Edwards, J. G., Fennell, D. A., Hubbard, R., Woolhouse, I., & Peake, M. D. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.03.005 · Cited by 136
Cho, J., Feld, R., Leighl, N. B., Opitz, I., Anraku, M., Tsao, M., Hwang, D. M., Hope, A. J., & de Perrot, M. E. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000078 · Cited by 129
Limited efficacy of imatinib mesylate in malignant mesothelioma: A phase II trial
Mathy, A., Baas, P., Dalesio, O., & van Zandwijk, N. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.04.010 · Cited by 127
Porcel, J. M., Hernández, P., Martínez‐Alonso, M., Bielsa, S., & Salud, A. (2014) · CHEST Journal · doi:10.1378/chest.14-0820 · Cited by 126
O'Brien, M. E. R., Watkins, D. J., Ryan, C., Priest, K., Corbishley, C. M., Norton, A., Ashley, S., Rowell, N. P., & Sayer, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj073 · Cited by 123
Creaney, J., Yeoman, D., Demelker, Y., Segal, A., Musk, A. W., Skates, S. J., & Robinson, B. W. S. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318180477b · Cited by 121
Ceresoli, G. L., Castagneto, B., Zucali, P. A., Favaretto, A. G., Mencoboni, M., Grossi, F., Cortinovis, D. L., Conte, G. D., Ceribelli, A., Bearz, A., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604442 · Cited by 119
Yıldırım, H., Metintaş, M., Entok, E., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c0a7ff · Cited by 117
Nowak, A. K., Stockler, M. R., & Byrne, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.147 · Cited by 111
Sterman, D. H., Alley, E. W., Stevenson, J. P., Friedberg, J. S., Metzger, S. T., Recio, A., Moon, E. K., Haas, A. R., Vachani, A., Katz, S. I., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2133 · Cited by 106
Pleural mesothelioma: little evidence, still time to do trials
Treasure, T., & Sedrakyan, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17108-0 · Cited by 103
Nowak, A. K., Millward, M., Creaney, J., Francis, R. J., Dick, I. M., Hasani, A., van der Schaaf, A. A., Segal, A., Musk, A. W., & Byrne, M. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31825f22ee · Cited by 102
The German Thorotrast Study: Recent Results and Assessment of Risks
KAICK, G. V., Dalheimer, A., Hornik, S., Kaul, A., Liebermann, D., Lührs, H., Spiethoff, A., Wegener, K., Wesch, H., & Luhrs, H. (1999) · Radiation Research · doi:10.2307/3580117 · Cited by 99
Coolen, J., Keyzer, F. D., Nafteux, P. R., Wever, W. D., Dooms, C., Vansteenkiste, J., Roebben, I., Verbeken, E. K., Leyn, P. D., Raemdonck, D. E. V., et al. (2012) · Radiology · doi:10.1148/radiol.12110872 · Cited by 96
Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
Hollevoet, K., Nackaerts, K., Thimpont, J., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1020oc · Cited by 95
Systematic review of trimodality therapy for patients with malignant pleural mesothelioma.
Cao, C. Q., Tian, D. H., Manganas, C., Matthews, P., & Yan, T. D. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2225-319x.2012.11.07 · Cited by 93
Plathow, C., Staab, A., Schmähl, A., Aschoff, P., ZUNA, I., Pfannenberg, C., Peter, S. H., Eschmann, S. M., & Klopp, M. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181817b3d · Cited by 91
Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma
van den Bogaert, D. P. M., Pouw, E. M., van Wijhe, G., Vernhout, R. M., Surmont, V. F. M., Hoogsteden, H. C., & van Klaveren, R. J. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31509-4 · Cited by 87
Hassan, R., Schweizer, C., Lu, K. F., Schüler, B., Remaley, A. T., Weil, S. C., & Pastan, I. H. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.07.016 · Cited by 84
Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial
MacLeod, N. J., Chalmers, A. J., O'Rourke, N., Moore, K., Sheridan, J., McMahon, L., Bray, C. A., Stobo, J., Price, A., Fallon, M., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000499 · Cited by 84
Cui, A., Jin, X.-G., Zhai, K., Tong, Z.-H., & Shi, H. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004145 · Cited by 81
Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary
Maziak, D. E., Gagliardi, A. R., Haynes, A. E., Mackay, J. A., & Evans, W. K. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2004.11.003 · Cited by 78
Rudd, R. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldp047 · Cited by 76
Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma
Halstead, J. C., Lim, E., Venkateswaran, R., et al. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.08.014 · Cited by 73
Nakas, A., Martin-Ucar, A. E., Edwards, J. G., & Waller, D. A. (2007) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.09.039 · Cited by 71
Cisplatin and Gemcitabine in Malignant Pleural Mesothelioma: A Phase II Study
Castagneto, B., Zai, S., Dongiovanni, D., Muzio, A., Bretti, S., Numico, G., & Botta, M. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000144852.75613.56 · Cited by 69
Batırel, H. F., Metintaş, M., Çağlar, H. B., Ak, G., Yumuk, P. F., Yıldızeli, B., & Yüksel, M. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.09.121 · Cited by 69
Mesothelioma from the Patient's Perspective
Clayson, H., Seymour, J. E., & Noble, B. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.09.003 · Cited by 64
The lived experience of patients with pleural mesothelioma
Hughes, N., & Arber, A. (2008) · International Journal of Palliative Nursing · doi:10.12968/ijpn.2008.14.2.28597 · Cited by 59
‘It's all bad news’: the first 3 months following a diagnosis of malignant pleural mesothelioma
Arber, A., & Spencer, L. (2012) · Psycho-Oncology · doi:10.1002/pon.3162 · Cited by 55
Routes of asbestos exposure and the development of mesothelioma in an English region.
Howel, D., Arblaster, L., Swinburne, L., Schweiger, M., Renvoize, E., & Hatton, P. (1997) · Occupational and Environmental Medicine · doi:10.1136/oem.54.6.403 · Cited by 54
Kang, L., Croswell, J. M., Koenig, H. C., Lam, C., & Maltz, A. (2011) · Europe PMC (PubMed Central) · Cited by 52
Stewart, D. J. (2003) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(03)00609-2 · Cited by 43
Malignant pleural mesothelioma: Computed tomography and correlation with histology
Seely, J. M., Nguyen, E. T., Churg, A., & Müller, N. L. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.004 · Cited by 40
Creaney, J., & Robinson, B. W. S. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.09.007 · Cited by 35
Treatment Options for Malignant Pleural Effusions: Patient Preference Does Matter
Maskell, N. A. (2012) · JAMA · doi:10.1001/jama.2012.5543 · Cited by 32
Self-citationCochrane corner: interventions for the management of malignant pleural effusions
Clive, A. O., Bhatnagar, R., Preston, N. J., Maskell, N. A., & Jones, H. E. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-208989 · Cited by 18
Self-citationA new standard for malignant pleural mesothelioma
Zauderer, M. G. (2015) · The Lancet · doi:10.1016/s0140-6736(15)01311-2 · Cited by 17
Gunatilake, S. C., Brims, F., Fogg, C., Lawrie, I., Maskell, N. A., Forbes, K., Rahman, N. M., Stephen Morris, A., Ogollah, R. O., Gerry, S., et al. (2014) · Trials · doi:10.1186/1745-6215-15-367 · Cited by 15
Self-citationChapman, E. K., Hughes, D., Landy, A., Whale, J., & Saunders, M. (2005) · Palliative & Supportive Care · doi:10.1017/s1478951505050078 · Cited by 14
(2003) · PubMed
Cited by
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Scherpereel, A., Opitz, I., Berghmans, T., Psallidas, I., Glatzer, M., Rigau, D., Astoul, P., Bölükbas, S., Boyd, J., Coolen, J., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00953-2019 · Cited by 273
Self-citationUpdate on biology and management of mesothelioma
Asciak, R., George, V., & Rahman, N. M. (2021) · European Respiratory Review · doi:10.1183/16000617.0226-2020 · Cited by 75
Ramundo, V., Zanirato, G., & Aldieri, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212216 · Cited by 46
The Usefulness of Biomarkers in Diagnosis of Asbestos-Induced Malignant Pleural Mesothelioma
Tanrıverdi, Z., Meteroglu, F., Yüce, H., Şenyiğit, A., Işcan, M., & Unüvar, S. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211017324 · Cited by 7
Metadata
- Authors
- Bibby, A. C., Tsim, S., Kanellakis, N., Ball, H., Talbot, D. C., Blyth, K. G., Maskell, N. A., & Psallidas, I.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2016-11-30
- Volume
- 25
- Issue
- 142
- Pages
- 472-486
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2559224373
- Cited by
- 316
- References
- 124
- FWCI
- 15.89
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.